Phase 1 Glutathione Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC

ChemotherapyNon-small Cell Lung CancerPD1 Antibody+1 more

The First Affiliated Hospital of Zhengzhou University80 enrolled1 locationNCT06896422

Suspended

Phase 1

Bioavailability of orally administered gamma-glutamylcysteine

This bioavailability trial represents an initial investigation in healthy volunteers to determine the potential of gamma-glutamylcysteine (GGC) to augment cellular glutathione levels. Glutathione depletion is associated with numerous age related disorders.

University of New South Wales18 enrolled1 locationACTRN12612000952842